List view / Grid view
BlueRock Therapeutics LP has established a new site for cell…
BlueRock Therapeutics LP has established a new site for cell therapy innovation on Bayer’s campus in Berlin, Germany.
Bayer to pay $1.5 billion upfront to acquire Viridion Therapeutics,…
Bayer to pay $1.5 billion upfront to acquire Viridion Therapeutics, thus strengthening its small molecule capabilities and expanding its reach into new modalities.
Bayer has signed a collaboration and services agreement with CureVac…
Bayer has signed a collaboration and services agreement with CureVac for the development of CVnCoV, a COVID-19 vaccine currently in late-stage trials.
Bayer will acquire KaNDy Therapeutics Ltd for an upfront cost…
Bayer will acquire KaNDy Therapeutics Ltd for an upfront cost of $425 million to expand its drug development pipeline in women’s healthcare.
